Person: Guo, Junling
Loading...
Email Address
AA Acceptance Date
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
Guo
First Name
Junling
Name
Guo, Junling
2 results
Search Results
Now showing 1 - 2 of 2
Publication Thermal Transition of Bimetallic Metal-Phenolic Networks to Biomass-Derived Hierarchically Porous Nanofibers(Wiley, 2018-03-15) Xiao, Gao; Chen, Wei; Tian, Fan; Richardson, Joseph; Tardy, Blaise; Liu, Minghua; Joshi, Neel; Guo, JunlingThe development and utilization of biomass resources could contribute to new materials for long-term sustainable energy storage and environmental applications, reduce environmental impacts, and meet the urgent need for green and sustainable development strategies. Herein, a bimetallic metal-phenolic network (MPN) was applied to incorporate different metallic element species into cattle skin and fabricate collagen-fiber-derived complex oxide nanofibers using natural polyphenols (Myrica tannins). Direct thermal transition of these biomass-MPN composites generates hierarchically porous nanofibers possessing micro- and mesoporous architectures along with a well-preserved macroscopic structure. The pore system and complex oxide composition provide excellent photocatalytic performance. This low-cost, simple, and readily scalable MPN-based approach provides a straightforward route to synthesize nanostructured materials directly from biomass, which could play important roles in a wide range of potential applications.Publication Systemic Tumour Suppression via the Preferential Accumulation of Erythrocyte-Anchored Chemokine-Encapsulating Nanoparticles in Lung Metastases(Springer Science and Business Media LLC, 2020-11-16) Zhao, Zongmin; Ukidve, Anvay; Krishnan, Vinu; Fehnel, Alexandra; Pan, Daniel; Gao, Yongsheng; Kim, Jayoung; Evans, Michael; Mandal, Abhirup; Guo, Junling; Muzykantov, Vladimir R.; Mitragotri, SamirEliciting immune responses against primary tumours is hampered by their immunosuppressive microenvironment and by the greater inaccessibility of deeper intratumoural cells. Metastatic tumour cells are however exposed to highly perfused and immunoactive organs, such as the lungs. Here, by taking advantage of the preferential co-localization of intravenously administered erythrocytes with metastases in the lung, we show that chemokine-encapsulating nanoparticles non-covalently anchored on the surface of injected erythrocytes result in local and systemic tumour suppression in mouse models of lung metastasis. Such ‘erythrocyte-anchored’ systemic immunotherapy led to the infiltration of effector immune cells into the lungs, to in situ immunization without the need of exogenous antigens, to the inhibition of the progression of lung metastasis, to significantly extended animal survival, and to systemic immunity that suppressed the growth of distant tumours after rechallenge. Erythrocyte-mediated systemic immunotherapy may represent a general and potent strategy for cancer vaccination.